Creative Medical Technology Holdings, Inc. (CELZ)

CELZ Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.01	0.01	0.09	0.09	0.16	0.17
Revenue Growth (YoY)	-87.77%	-89.84%	0.96%	-46.65%	-0.60%	33.04%
Cost of Revenue	0	0	0.03	0.05	0.05	0.05
Gross Profit	0.01	0.01	0.06	0.04	0.11	0.12
Selling, General & Admin	3.46	3.56	3.94	2.96	1.16	1.22
Research & Development	2.07	1.97	6.27	0.11	0	0
Other Operating Expenses	0.1	0.09	0.09	0.09	0.07	0.03
Operating Expenses	5.64	5.63	10.3	3.17	1.23	1.25
Operating Income	-5.63	-5.62	-10.24	-3.13	-1.11	-1.13
Interest Expense / Income	0	0	0	4.28	1.23	1.9
Other Expense / Income	-0.35	-0.33	-0.1	-26.62	33.98	5.46
Pretax Income	-5.28	-5.29	-10.14	19.21	-36.33	-8.48
Net Income	-5.28	-5.29	-10.14	19.21	-36.33	-8.48
Shares Outstanding (Basic)	1	1	1	0	0	0
Shares Outstanding (Diluted)	1	1	1	0	0	0
Shares Change	0.98%	28.76%	236.51%	460.63%	2700.68%	164.92%
EPS (Basic)	-3.74	-3.76	-9.28	73.70	-626.90	-4100.00
EPS (Diluted)	-3.74	-3.76	-9.28	56.10	-626.90	-4100.00
Free Cash Flow	-5.08	-8.03	-7.8	-2.22	-0.43	-1.21
Free Cash Flow Per Share	-3.58	-5.70	-7.13	-8.51	-7.50	-586.42
Gross Margin	60.00%	60.00%	67.84%	45.36%	69.24%	72.51%
Operating Margin	-62557.88%	-62445.91%	-11562.50%	-3562.17%	-677.71%	-682.88%
Profit Margin	-58624.39%	-58739.71%	-11449.26%	21892.75%	-22082.21%	-5126.09%
Free Cash Flow Margin	-56478.97%	-89198.72%	-8800.19%	-2524.99%	-264.17%	-732.99%
EBITDA	-5.18	-5.19	-10.05	23.58	-35.03	-6.56
EBITDA Margin	-57504.01%	-57688.78%	-11345.33%	26873.17%	-21294.13%	-3964.47%
Depreciation & Amortization	0.1	0.09	0.09	0.09	0.07	0.03
EBIT	-5.28	-5.29	-10.14	23.49	-35.1	-6.59
EBIT Margin	-58624.39%	-58739.71%	-11449.26%	26768.24%	-21334.74%	-3980.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).